In the BioHarmony Drug Report Database

"Preview" Icon

Hexocyclium

Tral (hexocyclium) is a small molecule pharmaceutical. Hexocyclium was first approved as Tral on 1982-01-01. It is known to target muscarinic acetylcholine receptor M3, muscarinic acetylcholine receptor M5, muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M4, and muscarinic acetylcholine receptor M1.

 

Trade Name

 

Tral
 

Common Name

 

hexocyclium
 

ChEMBL ID

 

CHEMBL1201325
 

Indication

 

 

Drug Class

 

Quaternary ammonium derivatives

Image (chem structure or protein)

Hexocyclium structure rendering